thiazoles has been researched along with Acute Liver Injury, Drug-Induced in 143 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (11.19) | 18.7374 |
1990's | 28 (19.58) | 18.2507 |
2000's | 68 (47.55) | 29.6817 |
2010's | 26 (18.18) | 24.3611 |
2020's | 5 (3.50) | 2.80 |
Authors | Studies |
---|---|
Alarcan, J; Braeuning, A; Kumar, V; Lampen, A; Lichtenstein, D; Luckert, C; Marx-Stoelting, P; Peijnenburg, A; Sharma, RP; Solano, MLM; Stoopen, G; Waizenegger, J | 1 |
Barnette, DA; Flynn, N; Matlock, M; Miller, GP; Osborn, LR; Schleiff, MA; Swamidass, SJ | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Carambia, A; Ghallab, A; Heeren, J; Herkel, J; Lohse, AW; Lommetz, C; Reinders, J; Schramm, C; Schuran, FA; Schwinge, D; Steudter, A; Wieschendorf, B; Zuehlke, S | 1 |
Alarcan, J; Braeuning, A; Lampen, A; Lichtenstein, D; Luckert, C; Marx-Stoelting, P; Sprenger, H; Waizenegger, J | 1 |
Church, RJ; Engelhardt, M; Howell, BA; Krähenbühl, S; Maurer, M; Messner, S; Paech, F; Schmitt-Hoffmann, AH; Spickermann, J; Wind, M; Witschi, AT; Woodhead, J | 1 |
El Euony, OI; El Okle, OS; Khafaga, AF; Lebda, MA | 1 |
Dong, F; Liu, W; Liu, X; Wu, X; Xu, J; Yang, Y; Zheng, Y | 1 |
Ding, Z; Du, D; Jiang, F; Jiang, J; Li, Z; Miao, Y; Wang, X; Yang, M; Yang, Y; Zhang, L; Zhang, X; Zhao, Y; Zhou, P; Zou, Z | 1 |
Abe, H; Doi, T; Inagaki, T; Kishi, F; Kishi, S; Minato, M; Murakami, T; Nagai, K; Nishimura, K; Obata, F; Ono, H; Shibata, E; Tamaki, M; Ueda, S | 1 |
Guo, X; Huang, L; Jia, K; Liao, X; Lu, H; Qiu, L | 1 |
Bergfeldt, L; Blomström-Lundqvist, C; Boriani, G; Botto, GL; Camm, AJ; Capucci, A; Goette, A; Hohnloser, SH; Israel, CW; Lozano, IF; Merino, JL | 1 |
Carmo, H; Dias da Silva, D; Lynch, A; Silva, E | 1 |
Atanackovic, D; Goekkurt, E; Harbaum, L; Marx, A; Schafhausen, P | 1 |
Lee, SK; Lee, SW; Park, HJ; Park, MC; Park, YB | 1 |
Melzig, MF; Sun, J; Xie, W; Zhang, X | 1 |
Baycu, C; Bektur, E; Burukoglu, D; Sahin, E; Taplamacioglu, F | 1 |
Kataoka, H; Rock, KL; Yang, K | 1 |
Han, DQ; Li, HY; Li, SP; Lv, GP; Meng, LZ; Zhao, J | 1 |
Krähenbühl, S; Liakoni, E; Rätz Bravo, AE | 1 |
Camacho, J; Gamez, J; Salvado, M; Simon-Talero, M; Vargas, V; Vidal, M | 1 |
Ghobara, MM; Hassan, MH | 1 |
Jones, HB; Martin, S; McCarthy, A; Page, C; Partridge, EA; Pickup, K; Ratcliffe, K; Rodrigues, A; Sarda, S; Schulz-Utermoehl, T; Wills, J; Wilson, ID | 1 |
Bonvin, A; Cotte, L; Descotes, J; Mesnil, A; Michallet, M; Nicolini, FE; Vial, T | 1 |
Becattini, B; Cellitti, JF; Chen, LH; De, SK; Emdadi, A; Karin, M; Kuntzen, C; Machleidt, T; Pellecchia, M; Riel-Mehan, M; Solinas, G; Stebbins, JL; Vazquez, J | 1 |
Gutiérrez-Macías, A; Ibarmia-Lahuerta, J; Martínez-Odriozola, P; Muñóz-Sánchez, J | 1 |
Akai, S; Fukami, T; Hosomi, H; Minami, K; Nakajima, M; Yokoi, T; Yoshikawa, Y | 1 |
Cai, Y; Fu, W; Ruan, J; Wei, A; Xiong, Z; Zhou, D | 1 |
Patki, PS; Vidyashankar, S | 1 |
Schiffer, CA; Zonder, JA | 1 |
Ilaiyaraja, N; Khanum, F | 1 |
Amin, HA; Edfawy, M; Hamed, AA; Hassan, MH; Mansour, A | 1 |
Ghaffari, H; Ghassam, BJ; Prakash, HS | 1 |
Azar, R; Banner, B; Bird, S; Bonkovsky, HL; Szabo, G | 1 |
Herrmann, A; Hesselbarth, N; Hippius, M; Hoffmann, A; Kuschel, U | 1 |
Hiratani, K; Iwata, M; Kobayashi, M | 1 |
Fackett, A; Hayden, MJ; Hewitt, NJ; Li, AP; Lloyd, S; Sakai, Y; Silber, PM | 1 |
Drinkard, CR; Graham, DJ; Shatin, D | 1 |
Kaplowitz, N; Lewis, JH; Watkins, PB | 1 |
Harvison, PJ; Kennedy, EL; Tchao, R | 1 |
Ackerson, L; Chan, KA; Everhart, JE; Gurwitz, JH; Hurley, JS; Martinson, B; Moseley, RH; Platt, R; Selby, JV; Terrault, N; Truman, A | 1 |
Graham, DJ; Green, L; Nourjah, P; Senior, JR | 1 |
Eguchi, T; Hino, T; Hisamochi, A; Ide, T; Koga, H; Koga, Y; Kumashiro, R; Kuwahara, R; Murashima, S; Ogata, K; Sata, M; Shishido, S; Tanaka, E; Ueno, T | 1 |
Furukawa, H; Haruyama, H; Izumi, T; Koga, T; Koishi, R; Matsushita, Y; Miyoshi, K; Nakamura, K; Shimizu, M; Sugawara, M; Takahashi, T; Tomita, A; Watanabe, I; Yasumo, H | 1 |
Camp, HS | 1 |
Chandramouli, J; Tolman, KG | 1 |
Lee, WM | 1 |
Cohen, SD; Dominick, PK; Roberts, JC; Slitt, AM | 1 |
Jun, W; Kim, KH; Lee, H; Lee, HS; Lee, KW; Won, NH | 1 |
Nakagawa, K; Takemura, N; Yamagami, T | 1 |
Bader, A; Meng, Q; Ru, J; Schmitmeier, S; Shen, C; Zhang, G | 1 |
Chaichantipyuth, C; Ngamtin, C; Poungshompoo, S; Pramyothin, P | 1 |
Cheng, X; Li, D; Meng, Q; Shen, C | 1 |
Curd, JG; Kaplan, RA; Robinson, CA; Sabharwal, UK; Vaughan, JH | 1 |
Bang, NU | 1 |
Goon, DJ; Nagasawa, HT; Yuzon, DL; Zera, RT | 1 |
Faini, D; Pagella, PG; Turba, C | 1 |
Carminati, R; Dubini, F; Falchi, M; Ferrario, F; Marcucci, A | 1 |
Bortolan-Gianese, P; Dubini, F; Falchi, M; Ferrario, F; Marcucci, A | 1 |
Hasegawa, M; Honda, Y; Hosokami, T; Ide, S; Ikeda, T; Kurebayashi, Y; Nakayama, A; Shimoto, Y; Suzuki, N; Yokohama, S | 1 |
Brendel, K; Daller, JA; Putnam, CW; Sawyer, JS; Yohem, K | 1 |
Kurita, C; Nagai, H; Nakano, S; Yamazaki, F; Yoshimura, T | 1 |
Hayata, M; Kurita, C; Nagai, H; Yoshimura, T | 1 |
Kim, ND; Kim, SH; Lee, JW; Lee, MG; Park, KJ; Yoon, WH | 1 |
Rommelspacher, H; Wlodek, L | 1 |
Nightingale, SL | 1 |
Imura, H | 1 |
Watkins, PB; Whitcomb, RW | 1 |
Gitlin, N; Juarbe, HM; Julie, NL; Lim, KN; Spurr, CL | 1 |
Carrasquillo, JA; Green, MV; Jeong, KS; Kim, IS; Kim, MK; Kobayashi, H; Paik, CH; Seidel, J; Soh, Y; Song, BJ | 1 |
de Groen, PC; Dinneen, SF; Vella, A | 1 |
Castellote, J; Porta, F | 1 |
Misbin, RI | 1 |
Hallal, H; Pérez-Gracia, A; Rausell, V; Salinas, E | 1 |
Hoekstra, JB; Kuck, EM; Wagenaar, LJ | 1 |
Fujishima, M; Hirahashi, T; Iwase, M; Okamura, C; Tsuji, H; Yamaguchi, M; Yoshinari, M | 1 |
Kaplowitz, N | 1 |
Zurlinden, J | 1 |
Andrade, RJ; Bellot, V; Bermudez, F; Cárdenas, F; Fernandez, MC; Garcia-Escaño, MD; Gomez-Outes, A; Hervás, A; Lucena, MI; Martin-Vivaldi, R; Nogueras, F; Pelaez, G; Romero, M; Salmerón, J | 1 |
Aguilar, J; Gavilán, F; Guijarro, J; Hernández, A; Larrauri, J; Lissen, E; Macías, J; Pineda, JA; Sayago, M | 1 |
Belda, G; Chuliá, T; Griñó, P; Jover, R; Martínez, R; Palazón, JM; Quílez, C | 1 |
Al-Salman, J; Arjomand, H; Kemp, DG; Mittal, M | 1 |
Bradford, BU; Brenner, D; Enomoto, N; Forman, D; Frey, W; Iimuro, Y; Kono, H; Nakagami, M; Rusyn, I; Thurman, RG; Yamashina, S | 1 |
Booth, AM; Caldwell, SH; Iezzoni, JC | 1 |
Malet, PF; Malik, AH; Prasad, P; Saboorian, MH; Thiele, DL | 1 |
Kuzuya, T | 1 |
Toyota, T; Ueno, Y | 1 |
Haruta, T; Iwata, M; Kobayashi, M | 1 |
Kanazawa, Y; Kawano, M | 1 |
Lefèbvre, PJ; Letiexhe, MR; Paquot, N; Scheen, AJ | 1 |
Chou, FP; Chu, CY; Lin, WL; Tseng, TH; Wang, CJ; Wang, JM | 1 |
Jagannath, S; Rai, R | 1 |
Baker, AL; Dolehide, K; Hart, J; Schiano, T | 1 |
Cho, MK; Kim, SG | 1 |
Bell, DS; Ovalle, F | 1 |
Castillo, JR; Hernandez, A; Torelló, J | 1 |
Crabb, D; Everett, L; Galli, A | 1 |
Bailey, CJ; Krentz, AJ; Melander, A | 1 |
Arioglu, E; Duncan-Morin, J; Gottlieb, N; Herion, D; Hoofnagle, J; Kleiner, DE; Lieberman, J; Premkumar, A; Reitman, ML; Reynolds, J; Rother, KI; Sebring, N; Sumner, AE; Taylor, SI | 1 |
Nori, U; Ravinuthala, RS | 1 |
Berg, CL; Prendergast, KA; Wisniewski, R | 1 |
Force, RW; Hachey, DM; O'Neil, MP | 1 |
Ducobu, J; Sternon, J | 1 |
Chen, TS; Ray, MB; Srinivasan, C; Williams, WM | 1 |
Bloomgarden, ZT | 1 |
Funk, WB; Lenhard, MJ | 1 |
Donnelly, R | 1 |
Biswas, P; Shakir, SA; Wilton, LV | 1 |
Gottlieb, S | 1 |
Caldwell, SH; Hespenheide, EE; von Borstel, RW | 1 |
Porterfield, LM | 1 |
Caldwell, SH | 1 |
Angulo, P; Lindor, KD | 1 |
Gale, EA | 1 |
McMorran, M; Vu, D | 1 |
Maeda, K | 1 |
Cohen, RI; Gouda, HE; Khan, A; Schwartz, J | 1 |
Iwata, M; Kobayashi, M | 1 |
Scheen, AJ | 1 |
Bucio, L; Damián-Matsumura, P; del Carmen, EM; Gutiérrez-Ruiz, MC; Hernández, E; Souza, V; Zaga, V | 1 |
Kram, MT; Lefkowitch, JH; May, LD; Rubin, DE | 1 |
Nierenberg, DW | 1 |
Tolman, KG | 1 |
Kaneko, T; Li, J; Qin, LQ; Sato, A; Wang, PY; Wang, Y | 1 |
Carminati, R; Falchi, M; Guadagni, L; Lodi, R; Nebuloni, R | 1 |
Ripani, G; Trasatti, GA | 1 |
Bierkenmayer, E; Ganser, V; Heldt, W; Herrmann, M; Steinbrecher, W | 1 |
Krishna, G; Pohl, LR | 1 |
Huang, HS; Jurima-Romet, M | 1 |
Charyulu, RL; Nagasawa, HT; Roberts, JC; Zera, RT | 1 |
Kubo, K; Ohishi, E; Yoshitake, I | 1 |
Boyd, MR; Ravindranath, V | 1 |
Drsata, J; Göckeritz, W; Odlerova, Z; Sidóova, E; Waisser, K | 1 |
Hazama, H; Murase, T; Okuno, H; Sameshima, Y; Shiozaki, Y | 1 |
Schütt, A; Siegers, CP; Strubelt, O | 1 |
Fels, H; Rauen, HM; Schriewer, H | 1 |
Lasana, JE; Rauen, HM; Schriewer, H; Tegtbauer, U | 1 |
Bain, LS; Hart, FD; Huskisson, EC; Littler, TR; Taylor, RT | 1 |
22 review(s) available for thiazoles and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Antithrombins; Atrial Fibrillation; Chemical and Drug Induced Liver Injury; Dabigatran; Digoxin; Dronedarone; Drug Interactions; Factor Xa Inhibitors; Heart Failure; Hospitalization; Humans; Mortality; Pyridines; Randomized Controlled Trials as Topic; Thiazoles | 2019 |
Hepatotoxicity of New Oral Anticoagulants (NOACs).
Topics: Administration, Oral; Animals; Anticoagulants; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles | 2015 |
Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate.
Topics: Algorithms; Antineoplastic Agents; Benzamides; Blast Crisis; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Combined Modality Therapy; Dasatinib; Drug Eruptions; Drug Interactions; Edema; Fusion Proteins, bcr-abl; Gastrointestinal Diseases; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Salvage Therapy; Thiazoles | 2006 |
[Pioglitazone].
Topics: Animals; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Edema; Humans; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha | 2002 |
Thiazolidinediones in diabetes: current status and future outlook.
Topics: Animals; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Humans; Hypoglycemic Agents; Lipids; Thiazoles; Weight Gain | 2003 |
Hepatotoxicity of the thiazolidinediones.
Topics: Chemical and Drug Induced Liver Injury; Chromans; Humans; Hypoglycemic Agents; Liver Failure, Acute; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration | 2003 |
Drug-induced hepatotoxicity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Chemical and Drug Induced Liver Injury; Chromans; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Humans; Hypoglycemic Agents; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Pharmaceutical Preparations; Pharmacology; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
[Ebrotidine-induced acute hepatitis].
Topics: Acute Disease; Adult; Benzenesulfonates; Chemical and Drug Induced Liver Injury; Chronic Disease; Female; Gastritis; Histamine H2 Antagonists; Humans; Thiazoles | 1999 |
Troglitazone. Is it all over?
Topics: Animals; Blood Glucose; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertriglyceridemia; Hypoglycemic Agents; Insulin Resistance; Liver Function Tests; Male; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
Hepatic injury due to troglitazone.
Topics: Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Liver; Middle Aged; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
[The development of thiazolidinedione drugs as anti-diabetic agents].
Topics: Animals; Chemical and Drug Induced Liver Injury; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Mice; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
[Clinical effect and side effect of troglitazone].
Topics: Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Hypoglycemic Agents; Liver Function Tests; Male; Middle Aged; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2000 |
[Clinical evaluation of pioglitazone].
Topics: Animals; Blood Glucose; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipid Metabolism; Male; Pioglitazone; Thiazoles; Thiazolidinediones | 2000 |
[Diabetes mellitus].
Topics: Blood Coagulation; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2000 |
[Thiazolidinediones].
Topics: Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
The role of hepatic peroxisome proliferator-activated receptors (PPARs) in health and disease.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chromans; Fatty Liver, Alcoholic; Kupffer Cells; Liver; Liver Diseases; Peroxisomes; Protein Isoforms; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2000 |
[Glitazones (thiazolidinedione)].
Topics: Animals; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Gluconeogenesis; Humans; Hypoglycemic Agents; Insulin Resistance; Rats; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors | 2000 |
Lessons from the glitazones: a story of drug development.
Topics: Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Drug Approval; Drug Therapy, Combination; Europe; Humans; Hypoglycemic Agents; Liver Failure; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone; United States | 2001 |
[Evaluation of thiazolidinedione derivative drugs for safety].
Topics: Animals; Chemical and Drug Induced Liver Injury; Chromans; Clinical Trials as Topic; Edema; Heart Failure; Humans; Hypoglycemic Agents; Pioglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Hepatotoxicity with thiazolidinediones: is it a class effect?
Topics: Aged; Chemical and Drug Induced Liver Injury; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Rosiglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Thiazolidinedione hepatotoxicity: a class effect?
Topics: Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
5 trial(s) available for thiazoles and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Mechanisms of hepatotoxicity associated with the monocyclic β-lactam antibiotic BAL30072.
Topics: Adenosine Triphosphate; Apoptosis; Cell Survival; Chemical and Drug Induced Liver Injury; Electron Transport; Glycolysis; Hep G2 Cells; Hepatocytes; Humans; Kupffer Cells; Lipopolysaccharides; Liver-Specific Organic Anion Transporter 1; Male; Microsomes, Liver; Monobactams; Solute Carrier Organic Anion Transporter Family Member 1B3; Thiazoles | 2017 |
Frentizole therapy in systemic lupus erythematosus.
Topics: Adult; Aged; Benzothiazoles; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney; Liver; Liver Cirrhosis; Lupus Erythematosus, Systemic; Middle Aged; Nephritis; Phenylurea Compounds; Thiazoles | 1980 |
Frentizole in systemic lupus erythematosus. Current status.
Topics: Benzothiazoles; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Colon; Drug Therapy, Combination; Humans; Interinstitutional Relations; Ischemia; Lupus Erythematosus, Systemic; Phenylurea Compounds; Placebos; Prednisone; Research Design; Thiazoles; Time Factors; United States | 1980 |
Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes.
Topics: Adipose Tissue; Adult; Aged; Body Composition; Chemical and Drug Induced Liver Injury; Child; Chromans; Drug Administration Schedule; Fatty Acids, Nonesterified; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipodystrophy; Liver; Male; Middle Aged; Prospective Studies; Respiratory Function Tests; Statistics, Nonparametric; Syndrome; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 2000 |
117 other study(ies) available for thiazoles and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Hepatotoxicity of the pesticides imazalil, thiacloprid and clothianidin - Individual and mixture effects in a 28-day study in female Wistar rats.
Topics: Animals; Body Weight; Chemical and Drug Induced Liver Injury; Female; Guanidines; Imidazoles; Kidney; Liver; Neonicotinoids; No-Observed-Adverse-Effect Level; Organ Size; Pesticides; Rats; Rats, Wistar; Risk Assessment; Thiazines; Thiazoles | 2020 |
Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam.
Topics: Activation, Metabolic; Biotransformation; Chemical and Drug Induced Liver Injury; Electrons; Epoxy Compounds; Humans; Hydroxylation; In Vitro Techniques; Kinetics; Meloxicam; Metabolic Networks and Pathways; Microsomes, Liver; Thiazines; Thiazoles | 2020 |
Aryl Hydrocarbon Receptor Activity in Hepatocytes Sensitizes to Hyperacute Acetaminophen-Induced Hepatotoxicity in Mice.
Topics: Acetaminophen; Animals; Basic Helix-Loop-Helix Transcription Factors; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Hepatocytes; Humans; Indoles; Liver; Liver Failure, Acute; Male; Mice; Mice, Knockout; Receptors, Aryl Hydrocarbon; Thiazoles | 2021 |
Transcriptomics analysis of hepatotoxicity induced by the pesticides imazalil, thiacloprid and clothianidin alone or in binary mixtures in a 28-day study in female Wistar rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Gene Expression Profiling; Guanidines; Imidazoles; Neonicotinoids; Pesticides; Rats; Rats, Wistar; Sequence Analysis, RNA; Thiazines; Thiazoles | 2021 |
Thiamethoxam induced hepatotoxicity and pro-carcinogenicity in rabbits via motivation of oxidative stress, inflammation, and anti-apoptotic pathway.
Topics: Animals; Antioxidants; Apoptosis; Carcinogens; Cell Survival; Chemical and Drug Induced Liver Injury; Cytokines; Inflammation; Liver; Male; Neonicotinoids; Nitro Compounds; Oxazines; Oxidative Stress; Rabbits; Thiamethoxam; Thiazoles | 2018 |
Crosstalk of oxidative damage, apoptosis, and autophagy under endoplasmic reticulum (ER) stress involved in thifluzamide-induced liver damage in zebrafish (Danio rerio).
Topics: Anilides; Animals; Antioxidants; Apoptosis; Autophagy; Chemical and Drug Induced Liver Injury; Endoplasmic Reticulum Stress; Liver; Malondialdehyde; Oxidative Stress; Thiazoles; Water Pollutants, Chemical; Zebrafish | 2018 |
Short-term use of MyD88 inhibitor TJ-M2010-5 prevents d-galactosamine/lipopolysaccharide-induced acute liver injury in mice.
Topics: Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Gene Expression Regulation; Kupffer Cells; Lipopolysaccharides; Mice; Molecular Structure; Myeloid Differentiation Factor 88; Piperazines; Thiazoles | 2019 |
Direct oral anticoagulant successfully used to treat an adult nephrotic patient complicated with portal vein thrombosis.
Topics: Administration, Oral; Adult; Anticoagulants; Chemical and Drug Induced Liver Injury; Factor Xa Inhibitors; Humans; Male; Nephrotic Syndrome; Portal Vein; Pyridines; Thiazoles; Treatment Outcome; Venous Thrombosis | 2019 |
Edoxaban (Lixiana°).
Topics: Anticoagulants; Atrial Fibrillation; Chemical and Drug Induced Liver Injury; Factor Xa Inhibitors; Hemorrhage; Humans; International Normalized Ratio; Pulmonary Embolism; Pyridines; Stroke; Thiazoles; Venous Thrombosis; Warfarin | 2017 |
Hepatotoxicity of tricyclazole in zebrafish (Danio rerio).
Topics: Animals; Antioxidants; Apoptosis; Chemical and Drug Induced Liver Injury; Oxidative Stress; Reactive Oxygen Species; Thiazoles; Water Pollutants, Chemical; Zebrafish | 2019 |
An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis.
Topics: Adenosine Triphosphate; Amphetamines; Apoptosis; Blotting, Western; Caspase 3; Caspase 7; Cell Death; Cell Line; Cell Survival; Central Nervous System Stimulants; Chemical and Drug Induced Liver Injury; Energy Metabolism; Flow Cytometry; Humans; Membranes; Mitochondria; Necrosis; Neutral Red; Real-Time Polymerase Chain Reaction; Reverse Transcription; RNA; Tetrazolium Salts; Thiazoles | 2013 |
Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity.
Topics: Adult; Antineoplastic Agents; Benzamides; Biopsy; Chemical and Drug Induced Liver Injury; Dasatinib; Drug Substitution; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Treatment Outcome | 2014 |
The concomitant use of meloxicam and methotrexate does not clearly increase the risk of silent kidney and liver damages in patients with rheumatoid arthritis.
Topics: Acute Kidney Injury; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Asymptomatic Diseases; Chemical and Drug Induced Liver Injury; Cohort Studies; Drug Therapy, Combination; Elasticity Imaging Techniques; Female; Humans; Liver; Male; Meloxicam; Methotrexate; Middle Aged; Odds Ratio; Prospective Studies; Thiazines; Thiazoles | 2014 |
Necrosis factor-alpha (TNF-alpha) response in human hepatoma HepG2 cells treated with hepatotoxic agents.
Topics: Acetaldehyde; Acetaminophen; Cell Line; Cell Survival; Central Nervous System Depressants; Chemical and Drug Induced Liver Injury; Coloring Agents; Ethanol; Humans; Liver; tert-Butylhydroperoxide; Tetrazolium Salts; Thiazoles; Tumor Necrosis Factor-alpha | 2014 |
Effects of nonsteroidal anti-inflammatory meloxicam on stomach, kidney, and liver of rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Kidney; Kidney Diseases; Liver; Meloxicam; Metaplasia; Pain; Rats; Rats, Sprague-Dawley; Stomach; Stomach Diseases; Thiazines; Thiazoles; Toxicity Tests | 2016 |
The xanthine oxidase inhibitor Febuxostat reduces tissue uric acid content and inhibits injury-induced inflammation in the liver and lung.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Death; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Enzyme Inhibitors; Febuxostat; Gastroesophageal Reflux; Gout Suppressants; Liver; Lung; Lung Injury; Male; Mice, Inbred C57BL; Necrosis; Neutrophil Infiltration; Peritoneum; Peritonitis; Thiazoles; Uric Acid; Xanthine Oxidase | 2015 |
Effect of sample preparation on components and liver toxicity of Polygonum multiflorum.
Topics: Cell Line; Cell Survival; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Ethanol; Hepatocytes; Humans; Limit of Detection; Plant Extracts; Polygonum; Reproducibility of Results; Solvents; Tetrazolium Salts; Thiazoles; Water | 2015 |
Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient.
Topics: Adult; Amyotrophic Lateral Sclerosis; Azathioprine; Benzamides; Biopsy; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Piperidines; Prednisone; Protein Kinase Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Severity of Illness Index; Thiazoles; Time Factors; Treatment Outcome | 2015 |
Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytokines; Cytoprotection; Gene Expression Regulation; Inflammation Mediators; Lipid Peroxidation; Liver; Liver Cirrhosis, Experimental; Male; Meloxicam; NF-kappa B; Oxidative Stress; Rats, Sprague-Dawley; Signal Transduction; Thiazines; Thiazoles | 2016 |
Acute liver effects, disposition and metabolic fate of [
Topics: Administration, Oral; Animals; Autoradiography; Bile; Bile Ducts; Cannula; Carbon Radioisotopes; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Feces; Male; Mice, Inbred C57BL; Thiazoles; Tissue Distribution | 2017 |
Dasatinib-induced acute hepatitis.
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Dasatinib; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Pyrimidines; Thiazoles | 2008 |
Identification of a new JNK inhibitor targeting the JNK-JIP interaction site.
Topics: Adaptor Proteins, Signal Transducing; Animals; Binding, Competitive; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Experimental; Dioxanes; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Liver Diseases; Mice; Molecular Mimicry; Phosphorylation; Protein Binding; Protein Kinase Inhibitors; Signal Transduction; Thiazoles | 2008 |
Meloxicam as a cause of drug-induced autoimmune hepatitis.
Topics: Actin Cytoskeleton; Alanine Transaminase; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Aminotransferases; Azathioprine; Back Pain; Bilirubin; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Meloxicam; Middle Aged; Prednisone; Thiazines; Thiazoles | 2010 |
An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and gamma-glutamylcysteine synthetase knockdown cells.
Topics: Adenoviridae; Animals; Cell Line; Chemical and Drug Induced Liver Injury; Coloring Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Evaluation, Preclinical; Gentian Violet; Glutamate-Cysteine Ligase; Glutathione; Hepatocytes; Kinetics; Microsomes, Liver; Nucleic Acid Conformation; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tetrazolium Salts; Thiazoles; Transfection | 2010 |
Antioxidant and hepatoprotective activity of ethanol extract of Arachniodes exilis (Hance) Ching.
Topics: Animals; Antioxidants; Benzothiazoles; Biphenyl Compounds; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Dryopteridaceae; Female; Hydrogen Peroxide; Hydroxyl Radical; Lipid Peroxidation; Male; Mice; Phytotherapy; Picrates; Plant Extracts; Protective Agents; Rhizome; Sulfonic Acids; Superoxides; Thiazoles | 2010 |
Liv.52 attenuate copper induced toxicity by inhibiting glutathione depletion and increased antioxidant enzyme activity in HepG2 cells.
Topics: Antioxidants; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Copper; DNA Fragmentation; Drug Combinations; Glutathione; Humans; Lipid Peroxidation; Medicine, Ayurvedic; Plant Extracts; Tetrazolium Salts; Thiazoles | 2010 |
Amelioration of alcohol-induced hepatotoxicity and oxidative stress in rats by Acorus calamus.
Topics: Acorus; Alkaline Phosphatase; Animals; Antioxidants; Benzothiazoles; Bilirubin; Biomarkers; Biphenyl Compounds; Chemical and Drug Induced Liver Injury; Ethanol; Lipid Peroxidation; Liver; Male; Malondialdehyde; Oxidative Stress; Peroxides; Phytotherapy; Picrates; Plant Extracts; Protein Carbonylation; Rats; Rats, Wistar; Rhizome; Sulfonic Acids; Thiazoles; Transaminases | 2011 |
Meloxicam modulates oxidative stress status, inhibits prostaglandin E2, and abrogates apoptosis in carbon tetrachloride-induced rat hepatic injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Carbon Tetrachloride; Caspase 3; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2 Inhibitors; Dinoprostone; Glutathione; Male; Malondialdehyde; Meloxicam; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Thiazines; Thiazoles | 2012 |
Hepatoprotective and cytoprotective properties of Hyptis suaveolens against oxidative stress-induced damage by CCl(4) and H(2)O(2).
Topics: Animals; Antioxidants; Carbon Tetrachloride; Cell Line; Cell Survival; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Hepatocytes; Histocytochemistry; Humans; Hydrogen Peroxide; Hyptis; Liver; Male; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Staining and Labeling; Tetrazolium Salts; Thiazoles | 2012 |
Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.
Topics: Alkaline Phosphatase; Chemical and Drug Induced Liver Injury; Cholestasis; Chromans; Female; Humans; Hypoglycemic Agents; Liver Function Tests; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones; Transaminases; Troglitazone | 2002 |
[Severe electrolyte imbalance and edema in therapy with rosiglitazone].
Topics: Chemical and Drug Induced Liver Injury; Contraindications; Diabetes Mellitus, Type 2; Edema; Humans; Hypoglycemic Agents; Liver Diseases, Alcoholic; Liver Function Tests; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones; Water-Electrolyte Imbalance | 2002 |
Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors.
Topics: Adenosine Triphosphate; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Alcohol Drinking; Chemical and Drug Induced Liver Injury; Chromans; Coloring Agents; Female; Formazans; Glutathione; Hepatocytes; Humans; Hypoglycemic Agents; Infant; Liver Diseases; Male; Middle Aged; Neutral Red; Oxazines; Rosiglitazone; Sex Factors; Smoking; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Troglitazone; Xanthenes | 2002 |
[Meta-analysis shows: insulin sensitizer is safe for the liver].
Topics: Chemical and Drug Induced Liver Injury; Chromans; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Hypoglycemic Agents; Meta-Analysis as Topic; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone.
Topics: Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Chromans; Female; Hospitalization; Humans; Hypoglycemic Agents; Incidence; Liver Failure, Acute; Male; Middle Aged; Retrospective Studies; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
Did this drug cause my patient's hepatitis?
Topics: Chemical and Drug Induced Liver Injury; Chromans; Humans; Pioglitazone; Product Surveillance, Postmarketing; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
Nephrotoxic and hepatotoxic potential of imidazolidinedione-, oxazolidinedione- and thiazolidinedione-containing analogues of N-(3,5-dichlorophenyl)succinimide (NDPS) in Fischer 344 rats.
Topics: Alanine Transaminase; Animals; Blood Glucose; Blood Urea Nitrogen; Chemical and Drug Induced Liver Injury; Fungicides, Industrial; Imidazoles; Kidney Diseases; Liver Diseases; Male; Oxazoles; Proteinuria; Rats; Rats, Inbred F344; Succinimides; Thiazoles | 2003 |
A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents.
Topics: Acute Disease; Adult; Aged; Chemical and Drug Induced Liver Injury; Chromans; Cohort Studies; Female; Humans; Hypoglycemic Agents; Incidence; Insulin; Liver; Liver Failure; Male; Metformin; Middle Aged; Proportional Hazards Models; Severity of Illness Index; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
Troglitazone-induced liver failure: a case study.
Topics: Age Distribution; Aged; Chemical and Drug Induced Liver Injury; Chromans; Chronic Disease; Confidence Intervals; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug and Narcotic Control; Female; Humans; Liver Failure; Liver Failure, Acute; Liver Function Tests; Male; Middle Aged; Odds Ratio; Probability; Registries; Risk Assessment; Severity of Illness Index; Sex Distribution; Survival Rate; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration | 2003 |
[A case of drug induced liver injury related pioglitazone].
Topics: Aryl Hydrocarbon Hydroxylases; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C9; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Middle Aged; Pioglitazone; Thiazoles; Thiazolidinediones | 2003 |
A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus.
Topics: Aged; Alanine Transaminase; Alleles; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Chromans; Data Collection; Diabetes Mellitus, Type 2; DNA; DNA Primers; Female; Gene Frequency; Genotype; Glutathione Transferase; Humans; Hypoglycemic Agents; Japan; Male; Middle Aged; Polymorphism, Genetic; Sex Characteristics; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion.
Topics: Acetaminophen; Animals; Blood Urea Nitrogen; Buthionine Sulfoximine; Chemical and Drug Induced Liver Injury; Cysteine; Glutathione; In Vitro Techniques; Kidney; Kidney Diseases; L-Iditol 2-Dehydrogenase; Liver; Liver Diseases; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Prodrugs; Protective Agents; Thiazoles; Thiazolidines | 2005 |
Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro.
Topics: Animals; Antioxidants; Catechin; Cells, Cultured; Chemical and Drug Induced Liver Injury; Ferric Compounds; Flavonoids; Free Radical Scavengers; Glutathione; Glutathione Disulfide; Hepatocytes; L-Lactate Dehydrogenase; Lipid Peroxidation; Liver; Male; Oxidation-Reduction; Oxidative Stress; Phenols; Plant Extracts; Polyphenols; Rats; Rats, Sprague-Dawley; Terminalia; Tetrazolium Salts; Thiazoles | 2005 |
Hepatocellular toxicosis associated with the alternate administration of carprofen and meloxicam in a siberian husky.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Chemical and Drug Induced Liver Injury; Dog Diseases; Dogs; Fatal Outcome; Female; Liver; Meloxicam; Steatitis; Thiazines; Thiazoles | 2005 |
Re-evaluation of tacrine hepatotoxicity using gel entrapped hepatocytes.
Topics: Albumins; Animals; Antidepressive Agents, Second-Generation; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cholinesterase Inhibitors; Cytochrome P-450 CYP1A2; Female; Fluvoxamine; Gels; Glutathione; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycyrrhetinic Acid; Hepatocytes; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Tacrine; Tetrazolium Salts; Thiazoles | 2007 |
Hepatoprotective activity of Phyllanthus amarus Schum. et. Thonn. extract in ethanol treated rats: in vitro and in vivo studies.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cytokines; Ethanol; Liver; Male; Phyllanthus; Plant Extracts; Rats; Rats, Wistar; Tetrazolium Salts; Thiazoles; Triglycerides | 2007 |
Investigation of rifampicin-induced hepatotoxicity in rat hepatocytes maintained in gel entrapment culture.
Topics: Acetylcysteine; Albumins; Animals; Antitubercular Agents; Cell Culture Techniques; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Drug Antagonism; Enzyme Inhibitors; Glutathione; Glycyrrhizic Acid; Hepatocytes; Lipid Metabolism; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Rifampin; Tetrazolium Salts; Thiazoles | 2009 |
Prodrugs of L-cysteine as liver-protective agents. 2(RS)-Methylthiazolidine-4(R)-carboxylic acid, a latent cysteine.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemistry; Cysteine; Magnetic Resonance Spectroscopy; Mice; Thiazoles | 1982 |
Effect of arginine thiazolidinecarboxylate on allyl alcohol hepatotoxicity in the rat.
Topics: 1-Propanol; Alanine Transaminase; Alkaline Phosphatase; Animals; Arginine; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Kinetics; Propanols; Rats; Thiazoles; Thiazolidines | 1981 |
[Normalizing effect of arginine thiazolidincarboxylate (ATCA) on hepatocytes in CCL4 poisoning in rats].
Topics: Animals; Arginine; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Male; Rats; Thiazoles; Thiazolidines | 1980 |
[Transmethylating activity of arginine thiazolidinecarboxylate (ATCA) in acute CCL4 poisoning and diet-induced steatosis in the rat].
Topics: Animals; Arginine; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Diet; Fatty Liver; Male; Methylation; Rats; Thiazoles; Thiazolidines | 1980 |
Synthesis and pharmacological activities of novel bicyclic thiazoline derivatives as hepatoprotective agents II. (7-Alkoxycarbonyl-2,3,5,6-tetrahydropyrrolo[2,1-b]thiazol-3-ylidend) acetamid derivatives.
Topics: Animals; Antibodies, Monoclonal; Bridged Bicyclo Compounds; Chemical and Drug Induced Liver Injury; Galactosamine; Liver; Liver Diseases; Mice; Rats; Structure-Activity Relationship; Thiazoles | 1995 |
The hepatotoxicities of endotoxin and ethanol comparisons in vitro using the precision-cut rat liver slice model.
Topics: Animals; Chemical and Drug Induced Liver Injury; Endotoxins; Ethanol; Female; In Vitro Techniques; L-Lactate Dehydrogenase; Liver; Male; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Thiazoles | 1994 |
Lymphocyte stimulation test with tetrazolium-based colorimetric assay for diagnosis of drug-induced allergic hepatitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Colorimetry; Drug Hypersensitivity; Female; Humans; Infant; Infant, Newborn; Lymphocyte Activation; Male; Middle Aged; Tetrazolium Salts; Thiazoles | 1994 |
Diagnosis of drug allergy by the lymphocyte stimulation test with the MTT [3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide] assay.
Topics: Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Female; Humans; Lymphocyte Activation; Male; Middle Aged; T-Lymphocytes, Cytotoxic; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1993 |
Effect of a hepatoprotective agent, YH-439, on the pharmacokinetics of furosemide and azosemide in rats.
Topics: Animals; Area Under Curve; Chemical and Drug Induced Liver Injury; Diuretics; Drug Interactions; Furosemide; Half-Life; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley; Sulfanilamides; Thiazoles | 1996 |
2-Methyl-thiazolidine-2,4-dicarboxylic acid as prodrug of L-cysteine. Protection against paracetamol hepatotoxicity in mice.
Topics: Acetaminophen; Animals; Antidotes; Chemical and Drug Induced Liver Injury; Glutathione; Liver; Liver Diseases; Liver Function Tests; Male; Mice; Oxidative Stress; Prodrugs; Thiazoles; Thiazolidines | 1997 |
From the Food and Drug Administration.
Topics: Appetite Depressants; Chemical and Drug Induced Liver Injury; Chromans; Drug Labeling; Fenfluramine; Heart Diseases; Humans; Hypoglycemic Agents; Mammography; Quality Control; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration | 1997 |
A novel antidiabetic drug, troglitazone--reason for hope and concern.
Topics: Administration, Oral; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
Hepatic dysfunction associated with troglitazone.
Topics: Alanine Transaminase; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus; Female; Humans; Male; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
Use of 99mTc-mercaptoacetyltriglycine (MAG3)-biocytin hepatobiliary scintigraphy to study the protective effect of a synthetic enzyme inhibitor on acute hepatotoxicity in mice.
Topics: Animals; Biliary Tract; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Liver; Liver Diseases; Lysine; Mice; Mice, Inbred BALB C; Necrosis; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Thiazoles | 1998 |
Fatal hepatotoxicity associated with troglitazone.
Topics: Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Male; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
[Toxic hepatitis caused by ebrotidine].
Topics: Benzenesulfonates; Chemical and Drug Induced Liver Injury; Histamine H2 Antagonists; Humans; Male; Middle Aged; Thiazoles | 1998 |
Troglitazone-associated hepatic failure.
Topics: Chemical and Drug Induced Liver Injury; Chromans; Humans; Hypoglycemic Agents; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
A Japanese case of liver dysfunction after 19 months of troglitazone treatment.
Topics: Chemical and Drug Induced Liver Injury; Chromans; Female; Humans; Hypoglycemic Agents; Japan; Middle Aged; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone | 1999 |
Avoiding hepatic injury from drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Chemical and Drug Induced Liver Injury; Chromans; Humans; Hypoglycemic Agents; Liver Diseases; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
Rezulin pulled in the UK.
Topics: Chemical and Drug Induced Liver Injury; Chromans; Drug and Narcotic Control; Humans; Hypoglycemic Agents; Thiazoles; Thiazolidinediones; Troglitazone; United Kingdom | 1998 |
Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist.
Topics: Acute Disease; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Benzenesulfonates; Bilirubin; Chemical and Drug Induced Liver Injury; Female; Histamine H2 Antagonists; Humans; Liver; Liver Failure; Male; Middle Aged; Necrosis; Thiazoles | 1999 |
Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine.
Topics: Adult; Anti-Ulcer Agents; Benzenesulfonates; Chemical and Drug Induced Liver Injury; Disease Progression; Female; Histamine H2 Antagonists; Humans; Liver Cirrhosis; Male; Middle Aged; Thiazoles; Time Factors | 1999 |
[Hepatoxicity due to ebrotidine: report of two cases].
Topics: Adult; Anti-Ulcer Agents; Benzenesulfonates; Chemical and Drug Induced Liver Injury; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Thiazoles | 1999 |
Hepatocellular injury in a patient receiving rosiglitazone. A case report.
Topics: Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver; Liver Function Tests; Male; Middle Aged; Monitoring, Physiologic; Rosiglitazone; Thiazoles; Thiazolidinediones | 2000 |
The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat.
Topics: Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Ethanol; Glutathione; Intubation, Gastrointestinal; Kupffer Cells; Liver; Liver Diseases; Male; Necrosis; NF-kappa B; Prodrugs; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; RNA, Messenger; Thiazoles; Thiazolidines; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
Troglitazone-associated hepatic failure.
Topics: Aged; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Fatal Outcome; Female; Hepatic Encephalopathy; Humans; Hyperlipidemias; Hypoglycemic Agents; Liver; Liver Failure; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Protective effect of Hibiscus anthocyanins against tert-butyl hydroperoxide-induced hepatic toxicity in rats.
Topics: Alanine Transaminase; Animals; Anthocyanins; Aspartate Aminotransferases; Carcinogens; Cell Survival; Chemical and Drug Induced Liver Injury; Free Radicals; Glutathione; L-Lactate Dehydrogenase; Lipid Peroxidation; Liver; Liver Function Tests; Male; Malvaceae; Quinones; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Thiazoles | 2000 |
Rapid-onset subfulminant liver failure associated with troglitazone.
Topics: Chemical and Drug Induced Liver Injury; Chromans; Humans; Hypoglycemic Agents; Liver Failure, Acute; Male; Middle Aged; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Severe but reversible hepatitis induced by troglitazone.
Topics: Biopsy; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver; Liver Function Tests; Male; Middle Aged; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Substituting for troglitazone (Rezulin).
Topics: Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Enhanced expression of rat hepatic microsomal epoxide hydrolase by methylthiazole in conjunction with liver injury.
Topics: Animals; Blotting, Northern; Chemical and Drug Induced Liver Injury; Cysteine; Densitometry; Dose-Response Relationship, Drug; Epoxide Hydrolases; Male; Methionine; Microsomes, Liver; Necrosis; Rats; Rats, Sprague-Dawley; RNA; Thiazoles | 2000 |
Late-onset troglitazone-induced hepatic dysfunction.
Topics: Aged; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver Function Tests; Male; Thiazoles; Thiazolidinediones; Time Factors; Treatment Refusal; Troglitazone | 2000 |
Liver injury caused by ebrotidine: a new example of the utility of the postmarketing surveillance.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Anti-Ulcer Agents; Benzenesulfonates; Chemical and Drug Induced Liver Injury; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Thiazoles | 2000 |
Correction: Liver injury and rosiglitazone.
Topics: Chemical and Drug Induced Liver Injury; Humans; Hypoglycemic Agents; Indoles; Phenylcarbamates; Rosiglitazone; Sulfonamides; Thiazoles; Thiazolidinediones; Tosyl Compounds | 2000 |
Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.
Topics: Chemical and Drug Induced Liver Injury; Chromans; Contraindications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Rosiglitazone toxicity.
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemic Agents; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones | 2000 |
Troglitazone-associated hepatotoxicity treated successfully with steroids.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Chromans; Humans; Prednisone; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Isolated elevation of alkaline phosphatase level associated with rosiglitazone.
Topics: Alkaline Phosphatase; Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemic Agents; Middle Aged; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones | 2000 |
Prevention of acetaminophen-induced liver toxicity by 2(R,S)-n-propylthiazolidine-4(R)-carboxylic acid in mice.
Topics: Acetaminophen; Aldehydes; Analgesics, Non-Narcotic; Animals; Chemical and Drug Induced Liver Injury; Cysteine; Dose-Response Relationship, Drug; Drug Interactions; Glutathione; Glutathione Disulfide; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Prodrugs; Protective Agents; Thiazoles | 2001 |
American Diabetes Association 60th Scientific Sessions, 2000: thiazolidinediones, obesity, and related topics.
Topics: Animals; Chemical and Drug Induced Liver Injury; Diabetes Mellitus; Hyperlipidemias; Hypoglycemic Agents; Insulin Resistance; Leptin; Lipids; Obesity; Societies, Medical; Thiazoles | 2001 |
Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis.
Topics: Adult; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
FDA reviews troglitazone.
Topics: Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver Diseases; Risk Factors; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration | 1999 |
Troglitazone and liver function abnormalities: lessons from a prescription event monitoring study and spontaneous reporting.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Chromans; England; Fatigue; Female; Humans; Hypoglycemic Agents; Liver; Liver Diseases; Liver Function Tests; Male; Middle Aged; Nausea; Product Surveillance, Postmarketing; Thiazoles; Thiazolidinediones; Troglitazone; Vomiting | 2001 |
Company played down drug's risks, report says.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chromans; Deception; Diabetes Mellitus, Type 2; Drug Industry; Government Regulation; Humans; Hypoglycemic Agents; Legislation, Drug; Thiazoles; Thiazolidinediones; Troglitazone; United States | 2001 |
Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin.
Topics: Aged; Anticholesteremic Agents; Antioxidants; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypoglycemic Agents; Liver Cirrhosis; Myositis; Simvastatin; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
What caused this patient's sudden liver dysfunction?
Topics: Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones | 2001 |
Efficacy and safety of troglitazone for lipodystrophy syndromes.
Topics: Adipocytes; Chemical and Drug Induced Liver Injury; Chromans; Hepatocytes; Humans; Lipodystrophy; Mitochondria; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Severe cholestatic hepatitis from troglitazone in a patient with nonalcoholic steatohepatitis and diabetes mellitus.
Topics: Adult; Chemical and Drug Induced Liver Injury; Cholestasis; Chromans; Diabetes Mellitus, Type 1; Fatty Liver; Female; Hepatitis; Humans; Hypoglycemic Agents; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.
Topics: Aged; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Female; Hematologic Diseases; Humans; Hypoglycemic Agents; Liver Failure; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones | 2001 |
Hepatocellular injury in a patient receiving pioglitazone.
Topics: Aged; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Liver Function Tests; Male; Pioglitazone; Thiazoles; Thiazolidinediones | 2001 |
Liver failure in a patient treated with long-term rosiglitazone therapy.
Topics: Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Humans; Hypoglycemic Agents; Liver Failure; Male; Rosiglitazone; Thiazoles; Thiazolidinediones | 2001 |
Cadmium induces alpha(1)collagen (I) and metallothionein II gene and alters the antioxidant system in rat hepatic stellate cells.
Topics: Animals; Antioxidants; Blotting, Northern; Cadmium; Calcium; Catalase; Cell Line; Chemical and Drug Induced Liver Injury; Collagen Type I; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hepatocytes; Lipid Peroxidation; Liver; Metallothionein; Neutral Red; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Superoxide Dismutase; Tetrazolium Salts; Thiazoles | 2002 |
Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy.
Topics: Bilirubin; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Liver; Middle Aged; Pioglitazone; Thiazoles; Thiazolidinediones; Transaminases | 2002 |
"Did this drug cause my patient's hepatitis?" and related questions.
Topics: Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Internal Medicine; Male; Middle Aged; Patient Care Planning; Physician's Role; Pioglitazone; Thiazoles; Thiazolidinediones | 2002 |
Summary for patients. Liver damage in a person taking the diabetes drug pioglitazone.
Topics: Bilirubin; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Liver; Middle Aged; Pioglitazone; Thiazoles; Thiazolidinediones; Transaminases | 2002 |
Troglitazone enhances the hepatotoxicity of acetaminophen by inducing CYP3A in rats.
Topics: Acetaminophen; Administration, Oral; Animals; Aryl Hydrocarbon Hydroxylases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chromans; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type 2; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Induction; Hypoglycemic Agents; Injections, Intraperitoneal; Male; Oxidoreductases, N-Demethylating; Rats; Rats, Mutant Strains; Rats, Wistar; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
[Antihepatotoxic activity of arginine thiazolidinecarboxylate in hepatitis induced by galactosamine in the rat].
Topics: Animals; Arginine; Chemical and Drug Induced Liver Injury; Female; Galactosamine; Rats; Thiazoles | 1979 |
[Therapeutic effectiveness of thiazolidinecarboxylate of arginine in psychiatric patients with hepatic disorders of toxic origin (alcohol, drugs)].
Topics: Adult; Aged; Antidepressive Agents; Arginine; Carboxylic Acids; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Hepatitis, Alcoholic; Humans; Male; Mental Disorders; Middle Aged; Thiazoles; Tranquilizing Agents | 1979 |
[On the pharmacology of piprozoline (author's transl)].
Topics: Amanitins; Animals; Bile; Bile Acids and Salts; Carbon Tetrachloride Poisoning; Cats; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Dogs; Female; Galactosamine; Lethal Dose 50; Male; Mice; Piperidines; Rats; Thiazoles | 1977 |
Deuterium isotope effect in bioactivation and hepatotoxicity of chloroform.
Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Chloroform; Cysteine; Cytochrome P-450 Enzyme System; Deuterium; Male; Microsomes, Liver; Phenobarbital; Rats; Thiazoles | 1978 |
Enalapril hepatotoxicity in the rat. Effects of modulators of cytochrome P450 and glutathione.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Biotransformation; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enalapril; Enzyme Induction; Glutathione; Inactivation, Metabolic; Liver; Liver Diseases; Male; Necrosis; Pregnenolone Carbonitrile; Protoporphyrins; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred F344; Sulfhydryl Compounds; Thiazoles; Thiazolidines | 1992 |
Protection against acetaminophen hepatotoxicity by ribose-cysteine (RibCys).
Topics: Acetaminophen; Animals; Antidotes; Chemical and Drug Induced Liver Injury; Cysteine; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Male; Mice; Prodrugs; Thiazoles; Thiazolidines | 1992 |
Hepatoprotective effects of 1-[(2-thiazolin-2-yl)-amino]acetyl-4-(1,3-dithiol-2-ylidene)-2,3,4,5- tetrahydro-1H-1-benzazepin-3,5-dione hydrochloride (KF-14363) in various experimental liver injuries.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Benzazepines; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Ethionine; Galactosamine; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred BALB C; Propionibacterium acnes; Rats; Rats, Inbred Strains; Thiazoles; Triglycerides | 1991 |
Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
Topics: Alanine Transaminase; Animals; Antimetabolites; Buthionine Sulfoximine; Chemical and Drug Induced Liver Injury; Cystine; Drug Interactions; Furans; Glutathione; Male; Maleates; Methionine Sulfoximine; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines | 1991 |
[Relation between chemical structure, antitubercular activity and hepatotoxicity of 2-alkylthio-6-benzamidobenzothiazoles].
Topics: Alanine Transaminase; Animals; Antitubercular Agents; Aspartate Aminotransferases; Benzamides; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemistry, Physical; Male; Mycobacterium tuberculosis; Rats; Rats, Inbred Strains; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Thiazoles | 1987 |
Effect of H2-receptor antagonists on acetaminophen-induced hepatic injury.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Cimetidine; Famotidine; Glutathione; Liver; Liver Diseases; Male; Methylcholanthrene; Microsomes, Liver; Ranitidine; Rats; Thiazoles | 1986 |
The curative effects of cysteamine, cysteine, and dithiocarb in experimental paracetamol poisoning.
Topics: Acetaminophen; Alcohols; Animals; Carboxylic Acids; Chemical and Drug Induced Liver Injury; Cysteamine; Cysteine; Dimercaprol; Enzymes; Flavonoids; Glutathione; Lethal Dose 50; Liver; Male; Mice; Penicillamine; Poisoning; Thiazoles; Thiocarbamates; Thioctic Acid | 1974 |
[The anti-hepatotoxic effect of aliphatic and heterocyclic mercapto compounds in CCl4-induced liver damage in the rat. II].
Topics: Acrylates; Alanine Transaminase; Alkaline Phosphatase; Amides; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Cholinesterases; Cyanides; Male; Rats; Sulfhydryl Compounds; Thiadiazoles; Thiazoles | 1973 |
[The effect of aliphatic and heterocyclic mercapto compounds on lipid peroxidation in CCl4-induced liver damage in the rat].
Topics: Acrylates; Amides; Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Cyanides; Cysteine; Endoplasmic Reticulum; Homocysteine; Male; Membranes; Microsomes, Liver; Oxidation-Reduction; Peroxides; Phospholipids; Rats; Structure-Activity Relationship; Sulfhydryl Compounds; Thiadiazoles; Thiazoles | 1973 |
Hepatic effects of fenzlozic acid.
Topics: Alanine Transaminase; Alkaline Phosphatase; Analgesics; Anti-Inflammatory Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Humans; Jaundice; Thiazoles | 1970 |